Home › Sickle Cell Disease › Georgia › Augusta
Sickle Cell Disease clinical trials in Augusta, GA
5 studies for Sickle Cell Disease are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RecruitingPhase 3
- Augusta University Georgia, Augusta
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RecruitingPhase 1
- Augusta University, Augusta
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RecruitingPhase 4
- Augusta University Georgia, Augusta
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RecruitingPhase 1
- Augusta University, Augusta
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RecruitingObservational study
- Augusta University, Augusta
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Atlanta, GA22 studies
- Washington, DC20 studies
- Memphis, TN18 studies
- Chicago, IL18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Cincinnati, OH10 studies
- Houston, TX10 studies
- Boston, MA10 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Endometrial Cancer7 studies
- Cancer (all types)7 studies
- Breast Cancer5 studies
- Myasthenia Gravis4 studies
- Blood Cancers4 studies
- Burkitt Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
- Non-Hodgkin Lymphoma4 studies
- Cervical Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.